Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
John Vissing is a professional medical entity and sole proprietorship operated by Professor John Vissing, a leading neurologist and Director of the Copenhagen Neuromuscular Center at Rigshospitalet in Denmark. The entity facilitates his work as a global Key Opinion Leader (KOL) in the field of neuromuscular diseases, including muscular dystrophies and metabolic myopathies. Professor Vissing provides expert consultancy to major pharmaceutical and biotechnology companies on clinical trial design, regulatory submissions, and therapeutic development. His research is particularly focused on Pompe disease, McArdle disease, and limb-girdle muscular dystrophies, where he has led numerous landmark clinical studies. The entity serves as a bridge between academic clinical research and industry-led drug development for rare muscle disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on John Vissing.